Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of the American Academy of Dermatology (JAAD)
Published October 17, 2026
Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the rando...
October 18, 2026
Medspoke
Medspoke
Urologic Oncology
Published October 17, 2026
00:00
--:--
Restricted mean survival time-based network meta-analysis of first-line therapies for metastatic ...
October 18, 2026
Share
Restricted mean survival time-based network meta-analysis of first-line therapies for metastatic clear cell renal cell carcinoma.
https://www.medspoke.co/channel_journal?id=689&tap_id=15873
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Urologic Oncology
Published October 17, 2026
Incidence and predictors of prolonged opioid use following nephrectomy for renal cell carcinoma: ...
October 18, 2026
Why are you reporting this TALK?
